The economic burden of chronic kidney disease and end-stage renal disease
V Wang, H Vilme, ML Maciejewski, LE Boulware - Seminars in nephrology, 2016 - Elsevier
The growing prevalence and progression of chronic kidney disease (CKD) raises concerns
about our capacity to manage its economic burden to patients, caregivers, and society. The
societal direct and indirect costs of CKD and end-stage renal disease are substantial and
increase throughout disease progression. There is significant variability in the evidence
about direct and indirect costs attributable to CKD and end-stage renal disease, with the
most complete evidence concentrated on direct health care costs of patients with advanced …
about our capacity to manage its economic burden to patients, caregivers, and society. The
societal direct and indirect costs of CKD and end-stage renal disease are substantial and
increase throughout disease progression. There is significant variability in the evidence
about direct and indirect costs attributable to CKD and end-stage renal disease, with the
most complete evidence concentrated on direct health care costs of patients with advanced …